UK Markets open in 6 hrs 44 mins

Thermo Fisher Scientific Inc. (0R0H.L)

LSE - LSE Delayed price. Currency in USD
Add to watchlist
585.47-0.60 (-0.10%)
At close: 07:00PM BST
Currency in USD

Valuation measures4

Market cap (intra-day) N/A
Enterprise value N/A
Trailing P/E N/A
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)N/A
Price/book (mrq)N/A
Enterprise value/revenue N/A
Enterprise value/EBITDA N/A

Trading information

Stock price history

Beta (5Y monthly) 0.82
52-week change 3N/A
S&P500 52-week change 3N/A
52-week high 3592.90
52-week low 3584.54
50-day moving average 3N/A
200-day moving average 3N/A

Share statistics

Avg vol (3-month) 3N/A
Avg vol (10-day) 3N/A
Shares outstanding 5402.58M
Implied shares outstanding 6N/A
Float 8391.17M
% held by insiders 10.38%
% held by institutions 190.99%
Shares short 4N/A
Short ratio 4N/A
Short % of float 4N/A
Short % of shares outstanding 4N/A
Shares short (prior month ) 4N/A

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 31.00
Trailing annual dividend yield 30.17%
5-year average dividend yield 4N/A
Payout ratio 4N/A
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Fiscal year

Fiscal year ends 31 Dec 2021
Most-recent quarter (mrq)02 Jul 2022

Profitability

Profit margin 17.37%
Operating margin (ttm)22.76%

Management effectiveness

Return on assets (ttm)7.70%
Return on equity (ttm)18.78%

Income statement

Revenue (ttm)42.82B
Revenue per share (ttm)108.96
Quarterly revenue growth (yoy)18.30%
Gross profit (ttm)19.64B
EBITDA 12.75B
Net income avi to common (ttm)7.44B
Diluted EPS (ttm)21.54
Quarterly earnings growth (yoy)-9.00%

Balance sheet

Total cash (mrq)1.89B
Total cash per share (mrq)4.82
Total debt (mrq)30.26B
Total debt/equity (mrq)71.25
Current ratio (mrq)1.65
Book value per share (mrq)98.24

Cash flow statement

Operating cash flow (ttm)8.84B
Levered free cash flow (ttm)5.56B